[On changes in the iron level and serum protein fractions after cytostatic therapy with N-oxide mustard gas and a nitrogen mustard phosphamide ester].
D000970:Antineoplastic Agents / Q000628:therapy*; D001798:Blood Proteins / Q000494:pharmacology*; D054697:Cytostatic Agents; D004117:Dimethoate; D007501:Iron / Q000097:blood*; D008466:Mechlorethamine; D009151:Mustard Gas; D009588:Nitrogen Mustard Compounds / Q000628:therapy*; D010087:Oxides; D012709:Serum Albumin; D000075462:Serum Albumin, Human; D012712:Serum Globulins
D000970:Antineoplastic Agents; D001798:Blood Proteins; D054697:Cytostatic Agents; D009588:Nitrogen Mustard Compounds; D010087:Oxides; D012709:Serum Albumin; D012712:Serum Globulins; D008466:Mechlorethamine; C008930:plasma protein fraction; D007501:Iron; D009151:Mustard Gas; D004117:Dimethoate; D000075462:Serum Albumin, Human
ANTINEOPLASTIC AGENTS/therapy; BLOOD PROTEINS/pharmacology; IRON/blood; NITROGEN MUSTARDS/therapy